Memorial Sloan Kettering Surgeon Prasad S. Adusumilli

Prasad S. Adusumilli, MD, FACS

Thoracic Surgeon & Cellular Therapist

My Role at MSK

Areas of Expertise

My Specialties

  • Lung Cancer
  • Mesothelioma
  • Metastatic Cancers to the Lung

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
English
Share

About Me

What I Do at MSK
  • Deputy Chief and Attending, Thoracic Service
  • Vice Chair for Translational Research, Department of Surgery
  • Co-Director, Mesothelioma Program
  • Member, Solid Tumors Cell Therapy, Cellular Therapeutics Center
  • Min H. & Yu-Fan C. Kao Chair in Thoracic Cancer
Get To Know Me

I am a surgeon with expertise in the diagnosis and treatment of thoracic cancers (cancers of the chest). These include lung cancer, mesothelioma, thymoma, mediastinal and chest wall tumors. I also specialize in cancers that have spread to the lung and pleura (layers of protective tissue that surround the lungs).

I see approximately 600 patients annually and have been caring for people with thoracic cancers for the past 15 years. I have expertise in the workup needed for the early diagnosis and accurate staging of thoracic cancers. For this, I use endoscopic methods such as endobronchial ultrasound (EBUS), robotic bronchoscopy, and video-assisted thoracoscopic surgery (VATS).

Read more

When newly diagnosed patients and their family members first meet me in the clinic, they are anxious. They can be overwhelmed by finding a treatment that will give them the best results and prevent the cancer from coming back. I take the time to explain the key factors that are driving the disease. We also discuss possible treatment options, the risks and benefits, and the expected short-term and long-term outcomes.

I like patients and family members to be reassured that we are considering every possible therapy and that we are focused on their quality of life. My goal is to help them feel confident in their care and be certain that we will treat them as a whole person — someone with a family, a job, and a desire not to be defined by their cancer diagnosis.

I work closely with thoracic pathologists, interventional radiologists, and pulmonologists to build a personalized treatment plan for each patient. My highly experienced clinical team includes a thoracic nurse and a nurse practitioner. We work together to deliver excellent care and provide personal attention to our patients and their family members.

As a surgeon and a scientist, I have a unique point of view. I treat patients and I study cancer in the lab. My research focuses on the development of biological markers to detect cancer that is at high-risk of coming back. I also study gene therapies, such as immunotherapy (enhancing patients’ own immune systems using genetic and cell engineering) and oncolytic viral therapy (killing cancer cells using genetically engineered viruses). I am working with my colleagues in medical and radiation oncology to use a combination of these treatments to help improve outcomes and lessen side effects.

Learn more about the accomplishments of the DoS.

My laboratory has led many discoveries about early-stage lung cancer and mesothelioma, and we have successfully used these findings to benefit patients. At their annual follow-up appointments after surgery, I make sure my patients are aware of these and other important developments that may help them.

Learn more about the Mesothelioma program at MSK. 

Our immunotherapy research has led to clinical trials for people with mesothelioma, lung cancer, and esophageal cancer (protocols 15-007, 16-040 and 20-328). This work is supported by the National Cancer Institute, the Department of Defense, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, and several other foundations.

I am also honored to mentor surgical trainees and research fellows. The high quality of their training is reflected in their presentations at national and international conferences and submissions to peer-reviewed publications.

In my spare time, I love to write and have published several satirical science fiction articles. I also enjoy cooking for my family and children and traveling internationally, especially visiting friends in rural areas of Europe.

My Role at MSK

A thoracic (thor-A-sik) surgeon is a doctor with special training in surgery on the chest, lungs, trachea (windpipe), and thymus.

A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.

Areas of Expertise

My Specialties

  • Lung Cancer
  • Mesothelioma
  • Metastatic Cancers to the Lung
  • Mediastinal and Chest Wall Tumors
  • Thymoma
  • Pleurectomy
  • Video-assisted thoracic Surgery (VATS)
  • Lobectomy
  • Robotic Bronchoscopy
  • Laparoscopy
Education & Honors

Education

  • MD, Guntur Medical College, India

Residencies

  • Surgery - Southampton University Hospitals, UK
  • General Surgery - Maimonides Medical Center
  • General Surgery - Lenox Hill Hospital

Fellowships

  • Cardiothoracic Surgery - Maimonides Medical Center
  • Thoracic Surgery - Memorial Sloan Kettering Cancer Center
  • Cardiothoracic Surgery - University of Pittsburgh Medical Center

Board Certifications

  • Thoracic Surgery
  • General Surgery

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA retirees only)

In Network Coverage Type
PPO

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

Blue Cross Blue Shield New York

In Network Coverage Type
PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

Blue Cross Health Plus

In Network Coverage Type
HMO

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

MSK has a tentative agreement with Cigna to continue coverage in 2024.

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage

In Network Coverage Type
PPO, HMO

Empire Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients

Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Adusumilli sees patients at two locations.

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Prasad S. Adusumilli discloses the following relationships and financial interests:

  • Abound Bio
    Professional Services and Activities
  • Adjuvant Genomics, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • AstraZeneca
    Professional Services and Activities
  • Atara Biotherapeutics
    Intellectual Property Rights; Professional Services and Activities
  • Bayer
    Professional Services and Activities
  • BioArdis LLC
    Professional Services and Activities
  • CARISMA Therapeutics Inc.
    Professional Services and Activities
  • Emerson Collective
    Professional Services and Activities
  • FirstThought, LLC
    Professional Services and Activities
  • Guidepoint Global Advisors
    Professional Services and Activities
  • ImmPACT Bio USA Inc.
    Professional Services and Activities
  • Imugene Limited
    Professional Services and Activities
  • Johnson & Johnson
    Professional Services and Activities
  • Kineticos
    Professional Services and Activities
  • MJH Life Sciences
    Professional Services and Activities
  • Novocure
    Professional Services and Activities
  • Orion Corporation
    Professional Services and Activities
  • Outpace Bio, Inc.
    Professional Services and Activities
  • Society for Immunotherapy of Cancer
    Professional Services and Activities
  • Takeda Pharmaceuticals
    Professional Services and Activities
  • University of Pittsburgh
    Professional Services and Activities
  • WC Communications, LLC
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures